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Hierarchical Interactions of Control Elements
Determine CD8a Gene Expression
in Subsets of Thymocytes and Peripheral T Cells
CD8b genes separated by 36 kb with the two genes
organized in the same transcriptional orientation (Gor-
man et al., 1988).
In contrast to conventional T cells such as those iso-
lated from lymph nodes or spleen, intraepithelial T lym-
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phocytes (IEL) located in epithelial cell layers exhibit aDivisions of *Molecular and ²Cellular Immunology
markedly different expression pattern of the CD4 andNational Institute for Medical Research
CD8 coreceptor molecules. While in mesenteric lymphThe Ridgeway
node cells (MEL) the ratio of CD4 to CD8 cells is 3:1,Mill Hill
this is almost reversed in IEL with 70% expressing CD8London NW7 1AA
and ,10% expressing CD4 (Maloy et al., 1991). Addition-United Kingdom
ally and as opposed to CD81 MEL, which almost exclu-
sively express the CD8ab heterodimer, a proportion of
abTCR positive IEL express the CD8aa homodimer andSummary
are thought to be extrathymically derived (Guy-Grand
et al., 1991), while the remainder of CD8aa1 cells belongCD4 and CD8 are crucial for the development and
to the gdTCR lineage (Rocha et al., 1992; Poussier andfunction of T cells. An intergenic deoxyribonuclease I
Julius, 1994). The expression of CD8aa homodimers onhypersensitive site region (cluster CIII) directs expres-
IEL indicates that the CD8a and CD8b genes can besion in mature CD8 T cells only. Here, we show that
differentially regulated in this T cell subset, a notiontwo further independent regions from the CD8 gene
supported by the observation that certain hybridomaslocus in conjunction with cluster CIII restore transgene
have extinguished CD8a gene expression but continueexpression in appropriate immature thymocytes. Dele-
to transcribe the CD8b gene (Gu and Gottlieb, 1992;tion of two of the intergenic cluster CIII DNaseI-HSS
Hwang et al., 1993).in homozygous mutant mice affects expression of
In an effort to identify the regulatory elements thatCD8aa homodimers on intraepithelial T cells (IEL), par-
control the expression of the CD8a and CD8b genes,ticularly on the gdTCR1 subset. Surprisingly, none of
we cloned the CD8 gene locus from cosmid and P1the thymocyte or peripheral abTCR T cell subsets are
libraries. Analyzing transgenic mice, we showed that aaffected by this mutation, indicating hierarchical acti-
region of 80 kb and containing the CD8a and CD8bvation of these elements within the different T cell
genes was sufficient for the developmentally regulatedsubsets.
and subset-specific expression of the cloned CD8ab
genes (Hostert et al., 1997a). Furthermore, using DNaseI-
Introduction HSS analysis, we identified three clusters of tissue-spe-
cific DNaseI-HSS within the injected fragment. Deletion
The expression of the coreceptor molecules CD4 and analysis using transgenic mice showed that one of these
CD8 is essential for the development and function of clusters of DNaseI-HSS (Cluster CIII; see Figure 1 below)
helper and cytotoxic T cells, respectively, and is often was sufficient to direct transgene expression of a linked
used as a marker to follow thymocyte maturation. Thus, reporter gene to the mature CD8 SP T cell subset (Ell-
prothymocytes enter the thymus as cells double nega- meier et al., 1997; Hostert et al., 1997b). In contrast,
tive for CD4 and CD8 [CD42CD82 (DN)] and then upregu- expression of the transgenic reporter was absent from
late both receptors to become CD41CD81 double posi- the immature DP thymocyte cell subset. In addition to
tive (DP). Following further maturation, DP thymocytes our own studies, DNaseI-HSS mapping carried out by
downregulate either one of the coreceptors to become other groups identified several tissue-specific DNaseI-
CD4 or CD8 single positive [CD41CD82 or CD42CD81 HSS (Landry et al., 1993). Two of these sites located
(SP)]. These cells, expressing only one of the corecep- immediately upstream of the CD8a gene (Landry et al.,
tors, migrate out of the thymus to populate peripheral 1993; CII-1 and CII-2: see Figure 1 below) were analyzed
lymphoid organs (Fowlkes and Pardoll, 1989). in more detail and shown to be present only in cell lines
Most thymocytes and T cells bearing an abTCR ex- expressing CD8 but not CD4, and their presence was
press CD8 as a disulphide-linked heterodimer com- thus correlated with transcription of CD8a (Landry et
posed of an a and a b chain (Ledbetter et al., 1981; al., 1993). Using a transfection-based assay, Lee et al.
Jay et al., 1982; Ledbetter and Seaman, 1982). The two (1994) were able to show that a negative regulatory ele-
chains are encoded by two distantly related but closely ment that binds as yet unidentified nuclear proteins is
linked genes, CD8a/Lyt-2 and CD8b/Lyt-3, respectively. located close to one of these DNaseI-HSS (DNaseI-HSS
The murine CD8 gene locus consists of the CD8a and CII-1). We have previously shown, however, that the
presence of these CII DNaseI-HSS alone were not suffi-
cient to direct expression of a CD8 transgene in any³ To whom correspondence should be addressed (email: d-kiouss@ thymocyte or T cell subset (Hostert et al., 1997a; Hostert,nimr.mrc.ac.uk).
1998).§ These authors contributed equally to this work.
In this article, we report the generation of trans-‖ Present address: Institute of Cancer Research, 237 Fulham Road,
London, SW3 6JB, United Kingdom. gene constructs that contain cluster CII DNaseI-HSS in
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Figure 1. DNaseI-HSS Site CII-2 Is Develop-
mentally Regulated
(A) Thymocyte (left and middle blots labeled
thymus) and splenocyte (right hand side blot
labeled spleen) nuclei were isolated from
C57Bl/10 or F5/Rag-12/2 mice and treated
with increasing concentrations of DNaseI (in-
dicated by wedges above the lanes). DNA
from the DNaseI-treated nuclei was digested
with BamHI and probed with a full-length
CD8a cDNA probe (see [B]). DNaseI-HSS are
indicated by hatched boxes to the right of the
Southern blot and are labeled CII-1 to CII-3.
Sizes (in kb) of comigrating BstEII digested l
DNA is indicated on the left.
(B) Map of the murine CD8 gene locus. Re-
striction enzyme sites are indicated by ver-
tical bars (B, BamHI), and the location of
DNaseI-HSS clusters are shown by vertical
arrows and labeled CI to CIV. Enlarged map
underneath shows the genomic region con-
taining DNaseI-HSS cluster CII and the exons
of the CD8a gene (filled black boxes above
the line). Cluster CII DNaseI-HSS are indi-
cated by vertical arrows (labeled CII-1 to
CII-3). Vertical bars indicate restriction en-
zyme sites (B, BamHI; H, HindIII). The location
of the full-length CD8a cDNA probe is shown
underneath the map, and the thin horizontal
arrows indicate the hybridizing fragment gen-
erated by the BamHI restriction enzyme site
and the inferred DNaseI-HSS.
conjunction with the previously described cluster CIII within the CD8 locus is required in a hierarchical manner
for the complex pattern and differential expression ofDNaseI-HSS. FACS analysis of transgenic mice carrying
these constructs showed that inclusion of the cluster the CD8a and CD8b genes in the different lymphocyte
subsets.CII DNaseI-HSS leads to restoration of transgene ex-
pression in the immature CD41CD81 DP thymocyte
compartment while retaining subset-specific expres-
sion in mature T cells. Furthermore, we show that inclu- Results
sion of a CD8b genomic fragment along with a CD8a
gene construct (CD8-CIII-123; Hostert et al., 1997b), that DNaseI-HSS Cluster CII Contains a Developmentally
Regulated DNaseI-HSSby itself cannot direct expression to the immature thy-
mocyte subset, also restores proper and developmen- The thymocyte-specific DNaseI-HSS cluster CII was
previously identified by long-range mapping using atally regulated expression of the reporter gene. Finally,
we report the analysis of mice that are deficient for two XhoI restriction digest and DNA isolated from DNaseI-
treated C57Bl/10 thymocyte nuclei (Hostert et al., 1997a).of the cluster CIII DNaseI-HSS (CIIID1,2 knockout mice).
Mice homozygous for the deletion show a reduction of In order to analyze the cluster CII DNaseI-HSS in more
detail, DNA obtained from DNaseI-treated C57Bl/10 thy-CD8a on IELs, particularly on gdTCR T cells and less
dramatically on abTCR T cells. Interestingly, expression mocyte nuclei was digested with BamHI and probed
with a full-length CD8a cDNA probe (Figure 1A, Thymus:of the CD8a and the CD8b genes in peripheral abTCR-
CD8ab T cells and thymocytes remains unperturbed. C57Bl/10). This probe recognizes a parent band of 8.2
kb and with increasing DNaseI concentration hybridizesWe conclude that the activity of multiple regulatory sites
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Figure 2. Transgene Constructs and Their Expression Pattern
Map of the CD8 gene locus showing the location of DNaseI-HSS (vertical arrows and labeled CI to CIV) and the CD8ab genes (filled boxes
above the line, translated exons; open boxes, untranslated). BamHI (B) restriction enzyme sites are shown by vertical bars and are labeled.
Fragments included in transgene constructs are indicated underneath the map by shaded boxes, and the reporter gene used in these constructs
is indicated on the left. The CD2-CIII-123 (hCD2 reporter gene) and CD8-CIII-123 (CD8a reporter gene) constructs have been described before
(Hostert et al., 1997b). In brief, the human CD2 promoter and cDNA or CD8a/Lyt-2.2 gene were linked to the cluster CIII DNaseI-HSS. These
basic constructs express in mature CD81 SP cells only. Additional fragments (CII) were cloned at the 39 end of the CD2-CIII-123 construct.
In the case of the CD8-CIII/b transgene construct, the CD8a-CIII-123 reporter gene was coinjected with the 15.5 kb CD8b genomic BamHI
fragment (see [A]). The expression pattern of the transgene constructs tested is indicated on the right of the corresponding construct. (1)
Expression of the reporter is detectable in this cell type; (-) expression of the reporter is not detectable; (N/T), not tested.
to additional fragments (sizes 5.5 kb [CII-1], 3.8 kb [CII- detected in splenocyte nuclei treated with any concen-
tration of DNaseI (Figure 1A, spleen: F5/Rag-12/2), indi-2], and 1.8 kb [CII-3]) that are not present in the zero
cating that this site is specifically present in thymocytesDNaseI lane (Figure 1A, Thymus: C57Bl/10). This probe
but not in mature CD8 SP T cells. The intensity of hybrid-also hybridizes to a second BamHI fragment of 3.0 kb
ization of the cluster CII DNaseI-HSS compared to thatthat contains exons VI and V of the CD8a gene (Figures
of the parent band appears to be lower in the F5/Rag-1A and 1B).
12/2 spleen sample; we attribute this to the lower per-In order to determine whether the cluster CII DNaseI-
centage of CD81 cells in spleen (approximately 30%HSS are also present in mature T cells, DNaseI-HSS
compared to .80% in thymus). In addition, hybridizationanalysis was performed on CD81 SP splenocytes. Since
of the CD8a cDNA probe to BamHI-digested DNA iso-we were unable to detect CD8-specific DNaseI-HSS
lated from DNaseI-treated spleenocyte nuclei of Rag-sites in DNA preparations from spleens of nontransgenic
12/2 mice did not reveal any DNaseI hypersensitivityC57Bl/10 mice due to the low content of CD8 expressing
(data not shown). We conclude that the pattern de-T cells, we have utilized a MHC class I restricted abTCR
scribed above is due to the CD81 T cells rather than thetransgenic mouse in which all peripheral T cells are
remaining cells in the F5/Rag-12/2 spleen.exclusively CD8 SP (F5/Rag-12/2; Mamalaki et al., 1992,
1993). Thus, nuclei were isolated from F5/Rag-12/2 thy-
Subset-Specific Reporter Gene Expression on CD8mocytes or splenocytes and subjected to DNaseI treat-
SP T Cells Is Retained in CD2-CIII/CIIment. DNA isolated from DNaseI-treated F5/Rag-12/2
Transgenic Mice
thymocyte nuclei was digested with BamHI and probed We have shown previously that a transgene containing
with the CD8a cDNA probe resulting in a pattern of the whole of cluster CII and the CD8a gene failed to
DNaseI-HSS identical to that of C57Bl/10 nontransgenic express in thymus or peripheral T cells (Hostert et al.,
mice (Figure 1A, thymus: F5/Rag-12/2). In contrast, DNA 1997a). In addition, we have shown that the CD2-CIII-
isolated from DNaseI-treated splenocyte nuclei and an- 123 transgene is only expressed in mature CD81 SP T
alyzed in the same manner showed a marked difference cells or thymocytes (Hostert et al., 1997b). In order to
in DNaseI-HSS distribution compared to the C57Bl/10 further examine the function of the cluster CII DNaseI-
and F5/Rag-12/2 thymus samples. The CD8a cDNA HSS, we generated transgenic mice carrying a construct
probe hybridizes to the 8.2 kb parent BamHI fragment consisting of CD2-CIII-123 in conjunction with cluster
and with increasing DNaseI concentration to additional CII sequences (a 4 kb HindIII fragment containing
bands of aproximately 5.5 kb and 1.8 kb, which cor- DNaseI-HSS sites CII-1 and CII-2) (Figures 2 and 3D).
respond to DNaseI-HSS CII-1 and CII-3 seen also in Transgenic mice with such constructs are designated
as CD2-CIII/CII.thymocytes. However, DNaseI-HSS CII-2 could not be
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Figure 3 shows the FACS analysis of lymphocytes
isolated from one of the eight founder CD2-CIII/CII
transgenic mice, a CD2-CIII-123 control-transgenic mouse
and, as a positive control, a Mg4 transgenic mouse that
expresses the hCD2 gene under the control of its own
locus control region (LCR) (Greaves et al., 1989). Expres-
sion of the transgenic hCD2 on CD4 and CD8 T cell
subsets was determined by three-color FACS analysis
(histograms to the right of the dot-plots). In CD2-CIII/
CII transgenic mice (Figure 3A), 91.7% of CD8a1 SP cells
expressed the transgenic hCD2 compared to 14.4% of
CD41 SP cells. All CD2-CIII/CII transgenic mice that
exhibited CD81 SP subset-specific expression showed
no hCD2 expression on the peripheral CD42CD82 DN
cell compartment (data not shown). Table 1 shows the
data for the remainder transgenic founder mice analyzed
for expression of hCD2 on CD8a1 and CD41 SP periph-
eral T cells.
In summary, six out of eight independent transgenic
founder mice carrying the CD2-CIII/CII transgenes ex-
pressed the hCD2 transgene in a subset-specific man-
ner on the CD81 SP mature T cells only. Two further
transgenic mice carrying the same transgene construct
also expressed hCD2 on the CD41 SP T cell subset, but
the proportion of hCD2-expressing cells was consis-
tently lower than that seen within the CD81 SP T cell
subset (see Table 1). It is probable that this is the re-
sult of a synergistic combination of elements present in
the hCD2 promoter and the site of integration of the
transgene.
Cluster CII DNaseI-HSS Restore Reporter Gene
Expression in Immature DP Thymocytes
Reporter gene expression in transgenic mice carrying
the cluster CIII DNaseI-HSS was absent from the CD41
CD81 immature DP thymocyte compartment (Ellmeier
et al., 1997; Hostert et al., 1997b). In order to determine
whether inclusion of DNaseI-HSS CII-1 and CII-2 re-
stored reporter gene expression in the DP thymocyte
subset, thymocytes were isolated from CD2-CIII/CII
transgenic mice and stained with antibodies specific for
hCD2, CD8, and CD4 (Figure 4). Expression of hCD2 on
the different thymocyte subsets is shown in the histo-
grams to the right of the corresponding dot-plots.
The CD2-CIII/CII transgenic mouse was found to ex-
press the transgene encoded hCD2 in the CD41CD81
(32.8%) and CD42CD81 (55.2%) thymocyte subsets
(Figure 4A). A lower proportion of cells expressing the
transgene (15.9%) was also observed in the CD42CD82
Figure 3. CD81 SP Subset Specificity Is Retained in the CD2-CIII/ DN thymocyte population. This is consistent with previ-
CII Construct ous observations in which the CD2-CIII-123 construct
(A±C) FACS analysis of CD2-CIII/CII transgenic lymph node cells (A), was found to express in a small proportion of the DN
CD2-CIII-123 control transgenic (B), and Mg4 (C) control transgenic
thymocyte compartment (Figure 4B). An even lower pro-mice. Detectable hCD2 expression was observed in the CD8 T cell
portion (9.1%) of the CD4 SP thymocyte subset wassubset in the CD2-CIII/CII transgenic mice (91.7%) and to a lower
positive for hCD2 (Figure 4A). We conclude that inclusionextent (14.4%) in the CD4 subset compared to 46.3% and 5.6%
(CD8 and CD4 subsets respectively) in the CD2-CIII-123 control of the DNaseI-HSS CII-1 and CII-2 from cluster CII in
transgenic mouse. hCD2 expression could be detected on 99.9%
of CD8 SP and 99.2% of CD4 SP cells in the Mg4 control transgenic
mouse. Seven further CD2-CIII/CII founder mice were analyzed for
hCD2 expression on CD41 and CD81 SP peripheral T cells: CD2- (D) Structure of the CD2-CIII/CII transgene construct. Exons are
CIII/CIIA (CD4: 5,2; CD8: 32.1), CD2-CIII/CIIB (CD4: 27.5; CD8: 84.2), shown as filled boxes above the line. DNaseI-HSS are indicated as
CD2-CIII/CIIC (CD4: 1.4; CD8: 63.4), CD2-CIII/CIID (CD4: 12.3; CD8: vertical arrows and are labeled (1±3 CIII; 1±2 CII). Restriction enzyme
39.3), CD2-CIII/CIIE (CD4: 2.5; CD8: 9.3), CD2-CIII/CIIF (CD4: 8.7; sites are indicated by vertical bars and are labeled C, ClaI; B, BamHI;
CD8: 63.3), and CD2-CIII/CIIG (CD4: 56.1; CD8: 91.0). S, SmaI; and H, HindIII.
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(data not shown). We conclude, therefore, that the CD8bTable 1. Expression of hCD2 on Peripheral T Cell Subsets in
genomic fragment does not interfere with subset-spe-CD2-CIII/CII Transgenic Mice
cific expression of the transgenic CD8a in the mature T
hCD2 Expression (%)
cell population.
Transgenic line CD4 CD8 As mentioned, the CD8-CIII-123 construct is silent in
the CD41CD81 DP thymocytes when injected on its ownCD2CIII/CIIA 5.2 32.1
(Ellmeier et al., 1997; Hostert et al., 1997b). In order toCD2CIII/CIIB 27.5 84.2
CD2CIII/CIIC 1.4 63.4 determine whether the coinjection of CD8b genomic
CD2CIII/CIID 12.3 39.3 sequences restores CD8a/Lyt-2.2 transgene expression
CD2CIII/CIIE 2.5 9.3 also in the CD41CD81 immature DP thymocyte cell sub-
CD2CIII/CIIF 8.7 63.3
set, thymocytes from CD8-CIII/b transgenic and CD8-CIII-CD2CIII/CIIG 56.1 91.0
123 control transgenic mice were stained with anti-CD8a/
Peripheral blood lymphocytes from CD2-CIII/CII transgenic founder Lyt-2.1 (endogenous CD8), anti-CD4, and anti-CD8a/
mice were stained with anti-hCD2, anti-CD8a, and anti-CD4 antibod-
Lyt-2.2 (transgenic CD8) antibodies and analyzed as de-ies. T cell subsets were identified by plotting CD4 against CD8,
scribed above. In contrast to the CD8-CIII-123 controlgated, and analyzed for hCD2 expression. The table shows the
transgenic mouse (Figure 5D), CD8a/Lyt-2.2 transgenepercentages of (CD41CD82; CD4) and (CD42CD81; CD8) cells that
express hCD2. expression was found to parallel that of the endogenous
CD8a/Lyt-2.1 allele (Figure 5C), with 96.6% of CD41
CD8a/Lyt-2.11 DP expressing the transgenic CD8a/Lyt-
the CD2-CIII-123 reporter gene restores expression in 2.2 allele. Similar expression patterns were observed in
the immature DP thymocyte compartment. the two further transgenic lines carrying the CD8-CIII/b
transgene.
The CD8b Gene Contains DNA Elements We therefore conclude that the 15.5 kb genomic CD8b
that Direct Expression to the Immature gene contains DNA regulatory elements that are distinct
DP Thymocyte Compartment from the cluster CII DNaseI-HSS described in the previ-
The differential expression of the CD8a and CD8b genes ous sections but that like CII, can direct transgene ex-
in gdTCR1 IEL and the persistent expression of CD8b pression of a reporter gene to the immature CD41CD81
in cultured cells that have extinguished CD8a expres- DP thymocyte cell subset when combined with cluster
sion (Gu and Gottlieb, 1992; Hwang et al., 1993) suggest CIII sequences.
that the CD8b gene is controlled by regulatory elements
that are distinct from those of CD8a. In addition, Kief-
fer et al. (1997) have shown that a human genomic frag- Deletion of Cluster CIII DNaseI-HSS Leads to Reduced
Expression of CD8a in Intraepethelial abTCR T Cellsment containing only the CD8b gene and surrounding
sequences expresses in a proper developmental and and a Major Reduction of gdTCR T Cells
Bearing CD8aa Homodimerssubset-specific manner in transgenic mice. In order to
examine elements contained in the CD8b locus, we gen- As previously shown, the cluster CIII DNaseI-HSS direct
reporter gene expression to the mature T cell subset.erated transgenic mice in which a 15.5 kb genomic
BamHI fragment and containing the CD8b gene (see In order to address the function of cluster CIII in situ,
we have generated mice that lack two of the three clusterFigure 2A) was coinjected with the CD8-CIII-123 reporter
construct (Figure 2) into the fertilized oocytes of CBA/ CIII DNaseI-HSS (CIII-1 and CIII-2). Thus, a targeting
construct was introduced into the germline of 129/SvCa mice (CD8-CIII/b). To determine the expression pat-
tern of the transgenic CD8a allele in a CBA/Ca back- embryonic stem cells by homologous recombination.
The targeting event replaces an 8 kb BamHI fragmentground, we have utilized antibodies that distinguish the
CD8a alleles (CD8a/Lyt-2.2, transgenic allele versus containing the cluster CIII DNaseI-HSS CIII-1 and CIII-2
with the neomycin resistance gene. Of 576 G418 resis-CD8a/Lyt-2.1, endogenous allele).
Figure 5 shows the FACS analysis of one of the CD8- tant clones screened by Southern blot analysis (Figure
6A), six were found to have undergone homologous re-CIII/b transgenic lines. Splenocytes were isolated from
CD8-CIII/b transgenic and CD8-CIII control trans- combination and the integrity of the locus was verified
with additional probes located upstream of the targetedgenic mice and triple stained with antibodies specific
for CD8a/Lyt-2.2 (transgenic CD8a), CD4, and CD8a/ region (data not shown). Two of the clones that had a
euploid karyotype were used to generate chimeric miceLyt-2.1 (endogenous CD8a). Expression of the trans-
genic CD8 in the different lymphocyte subsets is shown by blastocyst injection. These in turn were bred and
progeny carrying the CIIID1,2 deletion mutation were iden-in the histograms to the right of the corresponding dot-
plots. In the CD8-CIII/b transgenic mice, 96.4% of T tified. Mice heterozygous and homozygous for this mu-
tation are designated CIII1/D1,2 and CIIID1,2/D1,2, respec-cells expressing the endogenous CD8a gene also ex-
pressed the transgenic CD8a/Lyt-2.2 allele, while only tively, in this report.
Figure 6B shows the Southern blot analysis of wild-4.1% of CD41 SP T cells were positive for the transgenic
CD8 (Figure 5A). This expression pattern is similar to type 129/Sv, CIII1/D1,2 heterozygous, and CIIID1,2/D1,2 ho-
mozygous mutant mice and confirms the predicted con-the one observed in the CD8-CIII-123 control transgenic
mice that express the transgenic CD8a on 50.8% of the version of the 4.8 kb wild-type HindIII fragment to a
smaller 4.2 kb mutant fragment, as detected by theT cells expressing the endogenous CD8a gene and on
1.8% of CD41 SP T cells (Figure 5B). Transgene expres- probe indicated in Figure 6A.
In order to examine the effect of the CIIID1,2 deletionsion was absent from the CD42CD82 DN compartment
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Figure 4. Cluster CII DNaseI-HSS Restore
Transgene Expression in Immature Thymo-
cytes
(A±C) FACS analysis of thymocytes isolated
from CD2-CIII/CII (A) transgenic, CD2-CIII-
123 (B), and Mg4 (C) control mice analyzed for
CD8, CD4, and hCD2 expression. hCD2 trans-
gene expression in CD2-CIII/CII transgenic
mice can be observed in the immature
CD41CD81 DP (32.8%) and mature CD81 SP
(55.2%) thymocyte subsets. Lower levels of
transgene expression are detectable in the
CD42CD82 (15.9%) and CD41CD82 (9.1%)
compartments.
(D) Structure of the CD2-CIII/CII transgene
construct. Exons are shown as filled boxes
above the line. DNaseI-HSS are indicated as
vertical arrows and are labeled (1±3 CIII; 1±2
CII). Restriction enzyme sites are indicated
by vertical bars and are labeled C, ClaI; B,
BamHI; S, SmaI; and H, HindIII.
on CD8a gene expression, splenocytes and thymocytes Mice that carry cluster CIII transgene constructs ex-
press the reporter transgene in CD8aa1 gut intraepithel-were isolated from wild-type 129/Sv or CIIID1,2/D1,2 homo-
zygous mutant mice and stained with anti-CD4 and anti- ial lymphocytes (IEL) (Ellmeier et al., 1997). In order to
examine the effect of the CIIID1,2 deletion on CD8a geneCD8a antibodies (Figure 6C). Surprisingly, FACS profiles
of T cell and thymocyte subsets identified by plotting expression in these cells, IEL were isolated and stained
with antibodies specific for gdTCR, CD8a, CD8b, andCD4 against CD8a were similar for both wild-type and
mutant mice with no significant differences in either CD8a/Lyt-2.2 (Figure 7). gdTCR1CD8b2 IEL were gated
as indicated in the dot-plot and analyzed for CD8a ex-percentages of subsets or CD8a mean fluorescence in-
tensity between the mice analyzed (Figure 6C). In addi- pression (Figure 7, left-hand side histograms). 72.4%
of gdTCR1CD8b2 IEL isolated from CIII1/D1,2 mice weretion, the expression of the CD8b gene was not altered
by this mutation (Figure 6, legend). found to express CD8a at levels comparable to those
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Figure 5. A CD8b Coinjected Fragment Re-
stores Reporter Gene Expression in Thymo-
cytes
Three-color fluorometric analysis of pe-
ripheral lymphocytes and thymocytes of
CD8-CIII/b transgenic and CD8-CIII-123 con-
trol-transgenic mice (see Figure 2 for con-
struct). Isolated spleen cells or thymocytes
were stained with anti-CD8a/Lyt-2.1, anti-
CD4, and anti-CD8a/Lyt-2.2 antibodies. Cell
populations were identified by plotting CD4
against CD8a/Lyt-2.1, gated as indicated in
the dot-plots, and analyzed for CD8a/Lyt-
2.2 transgene expression in the histograms
shown to the right of the corresponding dot-
plot.
(A and B) FACS profiles of splenocytes iso-
lated from CD8-CIII/b transgenic (A) and
CD8-CIII-123 control-transgenic (B) mice and
analyzed as described above. Transgene ex-
pression was specifically present only in the
CD8a/Lyt-2.11 SP T cell population.
(C and D) FACS profiles of thymocytes iso-
lated from the CD8-CIII/b (C) and CD8-CIII-
123 control-transgenic (D) mice and analyzed
in the same manner.
found in 129/Sv control mice. In contrast, only 16.4% and therefore a mutation in one allele may disturb the
expression of the other. In order to address whether theof gdTCR1CD8b2 IEL isolated from CIIID1,2/D1,2 mice were
found to fall into the CD8a positive gate and expressed influence of the deletion of cluster CIII DNaseI-HSS is
restricted to the cis CD8a allele, we crossed the CIIID1,2CD8a at 10-fold-lower levels compared to 129/Sv con-
trol mice. In addition, abTCR1CD8b2 IEL expressing chimeric mice (carrying the mutated CIII cluster up-
stream of the CD8a/Lyt-2.2 allele) to DBA/2 (expressingCD8aa homodimers showed a 3-fold reduction of CD8a
expression in CIIID1,2/D1,2 animals compared to 129/Sv the wtCD8a/Lyt-2.1 allele) nontransgenic mice. IEL were
wild-type control mice (data not shown). isolated from the resulting mice carrying a wild-type
CD8a/Lyt-2.1 and a mutant CIIID1,2 targeted CD8a/Lyt-
2.2 allele (designated as CIII1/D12 in this paper). TheseCluster CIII Expression Control Is Restricted
to the cis Allele mice were stained with antibodies specific for gdTCR,
CD8a, CD8a/Lyt-2.2, and CD8b (Figure 7). CD8a/Lyt-It is possible that regulatory elements can exert their
effects in trans via a diffusible product (RNA or protein) 2.2 expression was absent from those gdTCR1CD8b2
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Figure 6. Deletion of DNaseI-HSS CIII-1 and CIII-2 by Homologous Recombination
(A) Diagram of the murine CD8 gene locus showing the targeting construct, DNaseI-HSS cluster CIII, and the targeted allele. The neomycin
gene (open box, labeled neo) was flanked by 8.5 kb 59 and 2.5 kb 39 homologous DNA sequences (shaded boxes). Restriction enzyme sites
are shown by vertical bars and are labeled B, BamHI; H, HindIII; X, XbaI. Vertical arrows indicate cluster CIII DNaseI-HSS, and the probe (a
1.7 kb XbaI±ScaI genomic fragment) used to detect homologous recombination events is shown as a solid horizontal bar. Horizontal arrows
illustrate the expected HindIII fragments hybridizing with the probe (4.2 kb targeted allele, 4.8 kb wild-type allele).
(B) Southern blot analysis of 129/Sv wild-type, CIII1/D1,2 heterozygous, and CIIID1,2/D1,2 homozygous mutant mice. The introduction of an artifical
HindIII site with the neomycin gene results in a reduction of a wild-type 4.8 kb HindIII fragment to a mutant 4.2 kb HindIII fragment.
(C) FACS analysis of 129/Sv wild-type and CIIID1,2/D1,2 mutant mice. Splenocytes or thymocytes were isolated and stained with anti-CD8a and
anti-CD4 antibodies. T cell and thymocyte subsets were resolved by plotting CD4 against CD8a and analyzed for CD8a expression. Percentages
of CD41 SP, CD81 SP, CD41CD81 DP, and CD42CD82 DN cell subsets are indicated in the quadrants and mean fluorescence intensities for
CD8a are also shown.
Mean fluorescence intensity (MFI) of CD8b staining on CD81 thymocytes and lymphocytes was also determined. Thymocytes or peripheral
lymphocytes were stained with antibodies specific for CD8a, CD4, and CD8b. CD8a positive cells were gated and analyzed for CD8b expression
from two 129/Sv wild-type and two CIIID1,2 homozygous mutant mice. CD8b MFI averages on CD8a1 lymph node cells were 63.42 in 129/Sv
mice compared to 60.49 in CIIID1,2 mice. In thymus, CD8b MFI averages on CD41CD81 DP were 60.56 in 129/Sv compared to 50.89 in CIIID1,2
mice. CD8b MFI on CD8a1 SP thymocytes were 63.39 in 129/Sv compared to 54.18 in CIIID1,2 mice.
IEL (CIII1/D1,2 histogram, right-hand side), whereas CD8a/ Discussion
Lyt-2.1 expression from the other allele was unaffected
(CIII1/D1,2 histogram, left-hand side). We conclude, there- CD8 subset-specific and developmentally regulated
expression has been achieved by the generation offore, that the cluster CIII DNaseI-HSS are unable to stim-
ulate CD8a gene transcription in trans. transgenic mice carrying a 80 kb genomic fragment from
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CIII reporter genes (Ellmeier et al., 1997; Hostert et al.,
1997b), recent reports have shown that deletion con-
structs that lacked either all introns or CD4 flanking
sequences were only expressed in the mature T cell
subsets and not the immature CD41CD81 DP thymocyte
subset in transgenic mice (Salmon et al., 1996; Adlam
et al., 1997; Uematsu et al., 1997).
Redundancy in CD8 Gene Regulatory Elements
In this study, we have extended our CD8 locus deletion
analysis. In particular, we sought to identify those regu-
latory elements that are important for expression in the
immature CD41CD81 thymocyte subset. Comparison of
DNaseI-HSS between peripheral CD81 SP T cells and
thymocytes showed that one of the cluster CII DNaseI-
HSS, CII-2 is absent in nuclei isolated from CD81 SP T
cells (see Figure 1), suggesting that this region may play
a role in the differential developmental control of the
CD8 locus. Thus, we have generated transgene con-
structs that contain the cluster CII sites in conjunction
with the previously identified cluster CIII DNaseI-HSS.
The inclusion of the two additional DNaseI-HSS from
the cluster CII in one of our transgene reporter gene
constructs restored the expression in immature DP thy-
mocytes while maintaining CD81 SP subset specificity in
peripheral lymphocytes. Thus, our experiments suggest
that in order to obtain proper developmental regulation
of CD8 expression both CIII and CII elements need to
be present, as the CII region by itself is unable to direct
expression of a CD8a reporter gene in any T cell subset.
In two of the eight CD2-CIII/CII transgenic mice gener-
ated, hCD2 expression was also observed in a propor-Figure 7. Cluster CIII Mutant Mice Lack CD8a Gene Expression on
gdTCR1CD8b2 Intraepithelial T Cells tion of CD41 SP T cells and thymocytes; we attribute
Intraepithelial T cells were isolated from murine gut of wild-type this to a combination of the pan-T cell specificity of the
129/Sv (bottom histograms), mutant CIIID1,2/D1,2 homozygous (middle hCD2 promoter and the site of transgene integration. In
histograms), and CIII1/D1,2 heterozygous (top histograms) mice. IEL the majority of the cases however, the CD8 regulatory
were stained with anti-dTCR, anti-CD8a, anti-CD8b, and anti-CD8a/ regions direct the expression of the reporter gene in a
Lyt-2.2-specific antibodies. dTCR positive T cells were gated as
CD8 subset-specific fashion.shown in the histogram (top left-hand side) and of these CD8b-IEL
Recent reports have shown that a 95 kb human geno-were identified by plotting CD8b against CD8a as indicated in the
dot-plot. Gated cells were analyzed for pan-CD8a expression (left- mic DNA fragment containing the CD8b gene and asso-
hand side histograms) or CD8a/Lyt-2.2 expression (right-hand side ciated DNaseI-HSS is sufficient for directing subset-
histograms). specific transgene expression (Kieffer et al., 1997). Thus,
we tested whether similar regulatory elements are pres-
ent within the murine CD8b gene and found that thethe murine CD8 gene locus (Hostert et al., 1997a). Fur-
ther deletion analysis identified a subregion, containing inclusion of a CD8b genomic fragment along with the
cluster CIII elements also restored reporter transgenea cluster of tissue-specific DNaseI-HSS (CIII), that is
sufficient for directing reporter gene expression to the expression in the CD41CD81 immature DP thymocyte
compartment. Therefore, the CD8b gene contains genemature CD81 SP T cell and intraepithelial T cells; strik-
ingly, expression of the transgenic reporter was absent regulatory elements that can substitute for the cluster
CII DNase-HSS discussed above. Thus, it appears thatfrom the immature DP thymocyte compartment in such
transgenic mice (Ellmeier et al., 1997; Hostert et al., there is a redundancy of functional elements that act in
concert within this gene locus. Experiments designed1997b). As opposed to CD8 regulation that (to our knowl-
edge so far) does not involve the activity of a silencer to further delineate those regulatory elements that are
responsible for directing DP transgene expression areelement, CD4 gene expression is controlled mainly by
the interactions between a pan-T cell±specific enhancer currently underway. Since all our constructs also in-
cluded the cluster CIII DNaseI-HSS, we still need tolocated upstream of the CD4 gene with the CD4 pro-
moter and a silencer element located within the first determine whether the CD8b regulatory elements on
their own can ensure the developmentally regulated pro-intron of the CD4 gene (Sawada and Littman, 1991; Blum
et al., 1993; Sawada et al., 1994; Siu et al., 1994; Duncan gram of CD8 gene expression in the absence of cluster
CIII sequences. In addition, since only a minority ofet al., 1996). However, in analogy to the mature T cell
and CD81 SP thymocyte-specific expression of CD8- abTCR1 IEL express the CD8ab heterodimer it will be
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interesting to determine also whether transgenic mice in gdTCR1CD8aa IEL. This suggests that when the CD8b
locus is suppressed, the cluster CII region, which is stillcarrying only the CD8b regulatory regions express the
reporter transgene only in these cells and not in those present in the knockout mice, is not able to sufficiently
activate transcription of the CD8a gene. This finding isIEL that exclusively carry the CD8aa homodimer. Such
an IEL subset specificity would not be unexpected since consistent with the observation that a CD8a transgene
containing only cluster CII sequences is unable to ex-recent experiments have shown that such cells have
never expressed the CD8b gene (Hamerman et al., 1997). press in any thymocyte or T cell subset.
Taken together, the data described in this paper sug-
gest the following model. Expression in immature dou-Is a Silencer Present in the CD8 Gene Locus?
ble positive thymocytes appears to require at least oneThe CD2-CIII/CII transgene construct includes two clus-
of two regulatory units within the CD8 locus. One ister CII DNaseI-HSS, one of which (CII-1) is in the vicinity
composed of DNaseI-HSS clusters CII and CIII whoseof a negative regulatory element identified in transfec-
interaction with each other is neccessary for early ex-tion experiments using cell lines (Lee et al., 1994). Our
pression of CD8a in thymocytes. The second unit istransgenic and gene targeting data so far do not indicate
located within the CD8b gene, and the CIIID1,2 mousethat there is a silencer in the CD8 gene locus that re-
data suggest that, in the presence of an active CD8bstricts expression of CD8 to the appropriate T cell and
locus, cluster CIII activity is redundant in CD8ab T cells.thymocyte subsets in transgenic mice. We are currently
In IEL, however, which have not activated the CD8bgenerating transgenic mice that carry either the con-
gene (possibly due to the differential microenvironmen-stitutive CII-1 or the developmentally regulated CII-2
tal signals), cluster CIII becomes important for CD8aDNaseI-HSS separately, in conjunction (or not) with the
gene expression. In conclusion, our data indicate thatcluster CIII DNaseI-HSS.
there are multiple regulatory elements in the CD8 gene
locus that may be redundant but exhibit a hierarchy in
Cluster CIII Targeted Mice their function.
In order to examine the role of the cluster CIII DNaseI-
HSS identified previously (Ellmeier et al., 1997; Hostert et Experimental Procedures
al., 1997b) we have generated mice that lacked selected
Transgene and Targeting Constructscluster CIII DNaseI-HSS. Transgenic constructs con-
The hCD2-CIII-123 transgene construct has been described else-taining sequences from the intergenic cluster CIII region
where (Hostert et al., 1997b). To generate the CD2-CIII/CII trans-
direct the expression of reporter transgenes to the ma- gene, the plasmid containing the hCD2-CIII-123 construct was di-
ture CD8ab T cell subset and CD8aa intraepithelial T gested with HpaI, and a blunted 4 kb HindIII genomic fragment
cells only. Thus, we were surprised to see that deletion containing the cluster CII DNaseI-HSS CII-1 and CII-2 was ligated
into the HpaI site. A 15.5 kb genomic BamHI fragment containingof two of the CIII DNaseI-HSS had no effect on the
the CD8b gene was subcloned from the cosmid cos2±5.3 (Hostert,expression of the CD8a locus in the CD8ab SP compart-
1998) into the BamHI site of pBluescript. For generation of the CD8-ment. In contrast, deletion of CIII-1 and CIII-2 from the
CIII/b mice, the CD8-CIII-123 construct was coinjected with the 15.5
locus severely affects the expression of CD8a in the kb BamHI fragment containing the CD8b gene.
gdTCR1CD8b2 IEL subset. This suggests that different For the generation of the targeting construct, the following steps
regulatory elements control CD8a gene expression were taken: in order to include an artifical HindIII site for screening
purposes, the loxP-flanked neomycin gene was excised from plas-within gdTCR1 IEL and conventional abTCR1 T cells. A
mid pL2-neo as a 1.2 kb XbaI-Sal I fragment, blunted and ligatedvery low level of CD8a expression could be observed
into the SmaI site of pBluescript that had its BamHI site mutatedin some of the gdTCR1 IEL. This is possibly due to the
to SalI. The neomycin gene flanked by loxP sites was then isolated
fact the the CIIID1,2 mutation described in this paper de- as a SalI fragment and ligated into pDneo. This was constructed
letes only two of the three cluster CIII DNaseI-HSS and by ligation of 2.9 kb ClaI±BamHI (upstream homology) and 2.5 kb
may also account for CD8a expression in T cells of BamHI±SalI (downstream homology) into the 6.0 kb XbaI±XhoI frag-
ment, lacking the original neo gene, of the pPNT vector (Tybulewiczthymic origin.
et al., 1991) that had its BamHI destroyed. Following mutation ofWhereas development of conventional abTCR1
the BamHI site between the two homologous sequences to SalI,CD8ab1 T cells is dependent on MHC class I, the latter
and ligation of the SalI fragment containing neo, a further 6.0 kb
is not necessary for gdTCR1CD8aa IEL differentiation BamHI±ClaI fragment upstream homology was ligated into the final
(Correa et al., 1992; Rocha et al., 1992). In addition, the vector as a ClaI fragment. This construct, GMTC, was linearized
different microenvironments in which MEL (thymus) and with NotI and used for ES cell transfection.
IEL (cryptopatches; Saito et al., 1998) mature may medi-
Transfection and Selection of ES Cellsate different signals that influence the gene expression
D3 embryonic stem cells (Doetschman et al., 1985) from 129/Svprogram of these cells (eg., Notch; Robey et al., 1996;
mice were maintained in the undifferentiated state by growth on
Washburn et al., 1997). Such differences may account a feeder layer of g-irradiated primary embryonic fibroblasts using
for absence of CD8b gene expression in CD8aa IEL. culture medium supplemented with leukaemia inhibitory factor (LIF)
Recent experiments that analyzed the methylation sta- (Mansour et al., 1988). Electoporation of 0.8 3 107 ES cells with 45
mg/ml of linearized GMTC and selection of homologous recombinedtus of cytosines within the CD8b 59 regulatory region
positive clones with G418 (250 mg or 300 mg/ml) and Gancyclovirhave shown that in these cells the CD8b gene has never
(2 mM) were carried out as described (Tybulewicz et al., 1991).been transcribed (Hamerman et al., 1997). It is possible
that the regulatory elements associated with the CD8b
Generation of Mutant and Transgenic Mice
gene and described in this report may also never have Chimeric mice were generated by injection of selected euploid ES
been active in the CD8aa IEL. In the CIIID1,2/D1,2 mice, we clones (modal chromosome number of 40) into 3.5-day blastocysts
derived from C57Bl/6 females and transfering them into the uteri ofobserved a dramatic effect on CD8a gene expression
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foster mothers. Chimeric males were bred to (C57Bl/6 3 DBA/2)F1 Molecular linkage of the Ly-3 and Ly-2 genes. Requirement of Ly-2
for Ly-3 surface expression. J. Immunol. 140, 3646±3653.or C57Bl/6 females and germline transmission was determined by
agouti coat colour. Mice transgenic for the abTCR from the F5 Greaves, D.R., Wilson, F.D., Lang, G., and Kioussis, D. (1989). Human
cytotoxic T cell clone were generated at NIMR and are described CD2 39-flanking sequences confer high-level, T cell-specific, posi-
(Mamalaki et al., 1992, 1993). Mice deficient for the RAG-1 gene tion-independent gene expression in transgenic mice. Cell 56,
were obtained from E. Spanopoulou (Spanopoulou et al., 1994). 979±986.
Mice transgenic for the transgene constructs were generated as Gu, J.J., and Gottlieb, P.D. (1992). Inducible functions in hybrids of
described (Hostert et al., 1997b) and kept in a conventional colony a Lyt-21 BW5147 transfectant and the 2C CTL line. Immunogenetics
under specific pathogen-free conditions at NIMR. 36, 283±293.
Guy-Grand, D., Cerf-Bensussan, N., Malissen, B., Malassis-Seris,
Flow Cytometric Analysis M., Briottet, C., and Vassalli, P. (1991). Two gut intraepithelial CD81
For FACS analysis, 106 thymocytes or T cells were stained with lymphocyte populations with different T cell receptors: a role for
the following antibodies in appropriate combinations: fluoresceine the gut epithelium in T cell differentiation. J. Exp. Med. 173, 471±481.
isocyanate (FITC)-conjugated anti-CD8a/Lyt-2.1 (49±11.1), FITC-con-
Hamerman, J.A., Page, S.T., and Pullen, A.M. (1997). Distinct methyl-
jugated anti-CD8 (YTS169), FITC-conjugated anti-hCD2 (MAR206), ation states of the CD8 beta gene in peripheral T cells and intraepi-
FITC-conjugated anti-CD8b (Pharmingen), FITC-conjugated anti-b thelial lymphocytes. J. Immunol. 159, 1240±1246.
TCR (H57.597), FITC-conjugated anti-dTCR (GL3), phycoerythrin
Hostert, A., Tolaini, M., Festenstein, R., McNeill, L., Malissen, B.,(PE)-conjugated anti-CD4 (H129.19, Boehringer Mannheim), PE-
Williams, O., Zamoyska, R., and Kioussis, D. (1997a). A CD8 genomicconjugated anti-CD8a (CT-CD8, Caltag), tricolor (TC)-conjugated
fragment that directs subset-specific expression of CD8 inanti-CD4 (CT-CD4, Caltag), TC-conjugated anti-CD8a (CT-CD8, Cal-
transgenic mice. J. Immunol. 158, 4270±4281.tag), and biotin-conjugated anti-CD8a/Lyt-2.2 (2.43). Cells stained
Hostert, A., Tolaini, M., Roderick, K., Harker, N., Norton, T., andwith biotin-conjugated antibodies were stained subsequently with
Kioussis, D. (1997b). A region in the CD8 gene locus that directsa second layer of streptavidin (SA)-red 670 (GIBCO-BRL) or SA-PE
expression to the mature CD8 T cell subset in transgenic mice.(Molecular Probes). Three- and four-color FACS analysis was carried
Immunity 7, 525±536.out on FACScan and FACSVantage Laser instruments, respectively,
Hostert, A. (1998). Identification of regulatory elements in the CD8and analyzed using Cell Quest or WINMDI software. IEL were iso-
gene locus. PhD thesis, University of London, London, Unitedlated from murine gut as described (Goodman and Lefrancois, 1988).
Kingdom.
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R., Piracha, R., Larijani, M., Heeney, M., Parnes, J.R., and Chamber-
lain, J.W. (1998). Distinct stage-specific cis-active transcriptional
mechanisms control expression of T cell coreceptor CD8a at dou-
ble- and single-positive stages of thymic development. J. Immunol.
161, 2254±2266.
